Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc | 3,163,517 | 2,920,509 | -243,008 | $93.92M | $54.35M | 46.57% | -$39.57M |
| CeriBell, Inc.(CBLL) | 2,205,661 | 2,205,661 | 0 | $42.90M | $53.80M | 46.09% | +$10.90M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 638,158 | 638,158 | 0 | $10.46M | $8.56M | 7.34% | -$1.90M |